Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity-Reference-Cited by-同舟云学术

Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity

Published:2016-04-18 Issue:5 Volume:22 Page:547-556
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Burridge Paul W,Li Yong Fuga^ORCID,Matsa Elena,Wu Haodi,Ong Sang-Ging,Sharma Arun,Holmström Alexandra,Chang Alex C,Coronado Michael J,Ebert Antje D,Knowles Joshua W,Telli Melinda L,Witteles Ronald M,Blau Helen M,Bernstein Daniel,Altman Russ B,Wu Joseph C

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.4087.pdf

Reference79 articles.

1. Lipshultz, S.E., Franco, V.I., Miller, T.L., Colan, S.D. & Sallan, S.E. Cardiovascular disease in adult survivors of childhood cancer. Annu. Rev. Med. 66, 161–176 (2015).

2. Giordano, S.H., Lin, Y.-L., Kuo, Y.F., Hortobagyi, G.N. & Goodwin, J.S. Decline in the use of anthracyclines for breast cancer. J. Clin. Oncol. 30, 2232–2239 (2012).

3. Lefrak, E.A., Pitha, J., Rosenheim, S. & Gottlieb, J.A. A clinicopathologic analysis of Adriamycin cardiotoxicity. Cancer 32, 302–314 (1973).

4. Von Hoff, D.D. et al. Risk factors for doxorubicin-induced congestive heart failure. Ann. Intern. Med. 91, 710–717 (1979).

5. Swain, S.M., Whaley, F.S. & Ewer, M.S. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97, 2869–2879 (2003).

Cited by 595 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translational research in pediatric cardiology;Nadas' Pediatric Cardiology;2025

2. Evolving therapeutics and ensuing cardiotoxicities in triple-negative breast cancer;Cancer Treatment Reviews;2024-11

3. Clinical trials in-a-dish for cardiovascular medicine;European Heart Journal;2024-09-13

4. Exploring the molecular mechanism of ginseng against anthracycline-induced cardiotoxicity based on network pharmacology, molecular docking and molecular dynamics simulation;Hereditas;2024-09-06

5. Characterizing PFAS hazards and risks: a human population-based in vitro cardiotoxicity assessment strategy;Human Genomics;2024-09-02